Filing Details
- Accession Number:
- 0001225208-25-004792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-06 16:37:45
- Reporting Period:
- 2025-05-02
- Filing Date:
- 2025-05-06
- Accepted Time:
- 2025-05-06 16:37:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1629277 | Bradley John Sorenson | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp, Global Operations | No | Yes | No | No |
Transaction Summary
| Sold: | 4,572 shares | Avg. Price: $104.54 | Total Value: $477,956.88 |
| Number of Shares After Transactions: | 18,705 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-05-02 | 4,204 | $0.00 | 25,195 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-05-02 | 1,918 | $104.93 | 23,277 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2025-05-05 | 4,572 | $104.54 | 18,705 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2025-05-02 | 4,204 | $0.00 | 4,204 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,204 | 2026-05-02 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.
- Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.
Billionaire Hedge Funds
